Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

v3.23.2
Net Loss Per Share (Tables)
 6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Net Loss Per Share, Basic and Diluted
The following table sets forth the computation of the Company's net loss per share attributable to common stockholders:
 
  Three Months Ended June 30, Six Months Ended June 30,
(in thousands, except share and per share data)(1)
  2023 2022 2023 2022
Net loss
 $ (10,676) $ (31,663) $ (34,203) $ (57,435)
Weighted average common stock outstanding, basic and diluted
 7,930,371  6,815,947  7,829,673  6,525,453 
Net loss per common share, basic and diluted
 $ (1.35) $ (4.65) $ (4.37) $ (8.80)
_____________________

(1) Share and per share amounts have been retroactively adjusted to reflect the Reverse Stock Split. See Note 2, Summary of Significant Accounting Policies, for additional detail.
Schedule of Antidilutive Securities Weighted-average Shares Outstanding of Securities That Could Potentially Dilute Basic Net Loss Per Share
The following table discloses the weighted-average shares outstanding of securities that could potentially dilute basic net earnings per share in the future that were not included in the computation of diluted net loss per share as the impact would be anti-dilutive:
  Three Months Ended June 30, Six Months Ended June 30,
  2023 2022 2023 2022
Restricted Stock(1)
222,692  405,444  236,053  410,218 
Warrants(2)
6,241,475  887,638  3,697,659  887,639 
_____________________

(1) Share amounts have been retroactively adjusted to reflect the Reverse Stock Split. See Note 2, Summary of Significant Accounting Policies, for additional detail.

(2) Subsequent to the Reverse Stock Split, every 13 common shares under warrants becomes exercisable for one share of common stock at an exercise price of $149.50 per share of common stock, which is reflected in the table above. See Note 2, Summary of Significant Accounting Policies, for additional detail.